Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Key monitoring of Sabin strain inactivated polio vaccine (Vero cells)
ChiCTR2000039988Phase 4Recruiting
- Sponsor
- Centers for Disease Control and Prevention
- Start
- Aug 2020
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of trivalent inactivated polio vaccine in poliomyelitis (2 arms), sponsored by Centers for Disease Control and Prevention. Primary endpoints: Incidence of adverse reactions/events (0–7 days after each dose), Incidence of adverse reactions/events (8–30 days after each dose) and 1 more. Started Aug 2020; status: recruiting.
02
Drugs
trivalent inactivated polio vaccine
03
Conditions
poliomyelitis
Beyond the preview
Go deeper on ChiCTR2000039988.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000039988.